Evidence map›Paper›PMID 23544014›Full record

ArticlePLoS genetics2013

Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors.

Stefan Nickels, Thérèse Truong, Rebecca Hein, Kristen Stevens, Katharina Buck, Sabine Behrens, Ursula Eilber, Martina Schmidt, Lothar Häberle, Alina Vrieling and 86 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 10 pooled it
18.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 10 syntheses or guidelines pooled it, 165 citations in OpenAlex.

  1. Genetic architecture of mammographic density as a risk factor for breast cancer: a systematic review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Correlations of IFN-γ genetic polymorphisms with susceptibility to breast cancer: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  7. Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Neoadjuvant chemotherapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and docetaxel.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Trial
  12. Review
  13. Review
  14. Evaluation ofCancer management and research · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Polygenic scores in cancer.Nature reviews. Cancer · 2023
    Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

96 authors at 20 institutions in 13 countries.

Stefan NickelsDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Thérèse Truong
Rebecca Hein
Kristen Stevens
Katharina Buck
Sabine Behrens
Ursula Eilber
Martina Schmidt
Lothar Häberle
Alina Vrieling
Mia Gaudet
Jonine Figueroa
Nils Schoof
Amanda B Spurdle
Anja Rudolph
Peter A Fasching
John L Hopper
Enes Makalic
Daniel F Schmidt
Melissa C Southey
Matthias W Beckmann
Arif B Ekici
Olivia Fletcher
Lorna Gibson
Isabel dos Santos Silva
Julian Peto
Manjeet K Humphreys
Jean Wang
Emilie Cordina-Duverger
Florence Menegaux
Børge G Nordestgaard
Stig E Bojesen
Charlotte Lanng
Hoda Anton-Culver
Argyrios Ziogas
Leslie Bernstein
Christina A Clarke
Hermann Brenner
Heiko Müller
Volker Arndt
Christa Stegmaier
Hiltrud Brauch
Thomas Brüning
Volker Harth
Genica Network
Arto Mannermaa
Vesa Kataja
Veli-Matti Kosma
Jaana M Hartikainen
kConFab
AOCS Management Group
Diether Lambrechts
Dominiek Smeets
Patrick Neven
Robert Paridaens
Dieter Flesch-Janys
Nadia Obi
Shan Wang-Gohrke
Fergus J Couch
Janet E Olson
Celine M Vachon
Graham G Giles
Gianluca Severi
Laura Baglietto
Kenneth Offit
Esther M John
Alexander Miron
Irene L Andrulis
Julia A Knight
Gord Glendon
Anna Marie Mulligan
Stephen J Chanock
Jolanta Lissowska
Jianjun Liu
Angela Cox
Helen Cramp
Dan Connley
Sabapathy Balasubramanian
Alison M Dunning
Mitul Shah
Amy Trentham-Dietz
Polly Newcomb
Linda Titus
Kathleen Egan
Elizabeth K Cahoon
Preetha Rajaraman
Alice J Sigurdson
Michele M Doody
Pascal Guénel
Paul D P Pharoah
Marjanka K Schmidt
Per Hall
Doug F Easton
Montserrat Garcia-Closas
Roger L Milne
Jenny Chang-Claude
German Cancer Research Center · DENational Cancer Institute · USThe University of Melbourne · AUUniversity of Cambridge · GBInserm · FRUniversity of Eastern Finland · FIUniversity of Sheffield · GBFriedrich-Alexander-Universität Erlangen-Nürnberg · DELondon School of Hygiene & Tropical Medicine · GBMayo Clinic in Florida · USMount Sinai Hospital · CAUniversität Hamburg · DEUniversity of Copenhagen · DKCancer Prevention Institute of California · USInstitute of Cancer Research · GBQIMR Berghofer Medical Research Institute · AUUniversity of California, Irvine · USAmerican Cancer Society · USCity Of Hope National Medical Center · USDana-Farber Cancer Institute · US

Funding

Hormone-Related CancersZIACP010126 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$103.5M
Laboratory of Translational GenomicsZIACP010201 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI PROKUNINA-OLSSON, LIUDMILA · 2010 to 2025
$91.2M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
CALIFORNIA TEACHERS STUDYR01CA077398 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERNSTEIN, LESLIE · 1998 to 2014
$29.7M
Northern California Cooperative Family Registry for Breast CancerU01CA069417 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M. · 1995 to 2010
$22.4M
METROPOLITAN NEW YORK REGISTRY OF BREAST CANCER FAMILIESU01CA069398 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI TERRY, MARY BETH · 1995 to 2010
$10.5M
ONTARIO REGISTRY FOR STUDIES OF FAMILIAL BREAST CANCERU01CA069467 · NCI · CANCER CARE ONTARIO · PI ANDRULIS, IRENE L. · 1995 to 2010
$10.4M
Philadelphia Breast Cancer Family RegistryU01CA069631 · NCI · FOX CHASE CANCER CENTER · PI DALY, MARY BERYL · 1995 to 2010
$7.4M
THE AUSTRALIAN BREAST CANCER FAMILY REGISTRYU01CA069638 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 1995 to 2010
$6.6M
Mayo Cancer Genetic Epidemiology Training ProgramR25CA092049 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M., VACHON, CELINE M · 2001 to 2018
$5.3M
A genome-wide association study for breast cancer in BRCA1 mutation carriersR01CA128978 · NCI · MAYO CLINIC ROCHESTER · PI COUCH, FERGUS JOSEPH · 2008 to 2012
$4.8M
Utah Breast Cancer Family RegistryU01CA069446 · NCI · UNIVERSITY OF UTAH · PI BUYS, SAUNDRA S · 1995 to 2010
$4.6M
Breast Cancer Now 2004NOV49Cancer Research UK 10118Cancer Research UK 10124Cancer Research UK 11022Cancer Research UK 16561Cancer Research UK 16565Cancer Research UK C1287/A10118Cancer Research UK C1287/A12014Cancer Research UK C490/A10119Cancer Research UK C490/A10124Cancer Research UK C490/A6187Intramural NIH HHSNCI NIH HHS CA-06-503NCI NIH HHS CA116201NCI NIH HHS CA122340NCI NIH HHS CA128978NCI NIH HHS CA69398NCI NIH HHS HHSN261200900010CNCI NIH HHS K05 CA152715NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA047147NCI NIH HHS R01 CA047305NCI NIH HHS R01 CA069664NCI NIH HHS R01 CA077398NCI NIH HHS R01 CA122340NCI NIH HHS R01 CA128978NCI NIH HHS R01 CA47147NCI NIH HHS R01CA69664NCI NIH HHS R01 CA77398NCI NIH HHS R25 CA092049NCI NIH HHS U01 CA069398NCI NIH HHS U01 CA069417NCI NIH HHS U01 CA069446NCI NIH HHS U01 CA069467NCI NIH HHS U01 CA069631NCI NIH HHS U01 CA069638NCI NIH HHS U01 CA69417NCI NIH HHS U01 CA69446NCI NIH HHS U01 CA69631NCI NIH HHS U01 CA69638
6 · The paper itself

Abstract

Various common genetic susceptibility loci have been identified for breast cancer; however, it is unclear how they combine with lifestyle/environmental risk factors to influence risk. We undertook an international collaborative study to assess gene-environment interaction for risk of breast cancer. Data from 24 studies of the Breast Cancer Association Consortium were pooled. Using up to 34,793 invasive breast cancers and 41,099 controls, we examined whether the relative risks associated with 23 single nucleotide polymorphisms were modified by 10 established environmental risk factors (age at menarche, parity, breastfeeding, body mass index, height, oral contraceptive use, menopausal hormone therapy use, alcohol consumption, cigarette smoking, physical activity) in women of European ancestry. We used logistic regression models stratified by study and adjusted for age and performed likelihood ratio tests to assess gene-environment interactions. All statistical tests were two-sided. We replicated previously reported potential interactions between LSP1-rs3817198 and parity (Pinteraction = 2.4 × 10(-6)) and between CASP8-rs17468277 and alcohol consumption (Pinteraction = 3.1 × 10(-4)). Overall, the per-allele odds ratio (95% confidence interval) for LSP1-rs3817198 was 1.08 (1.01-1.16) in nulliparous women and ranged from 1.03 (0.96-1.10) in parous women with one birth to 1.26 (1.16-1.37) in women with at least four births. For CASP8-rs17468277, the per-allele OR was 0.91 (0.85-0.98) in those with an alcohol intake of <20 g/day and 1.45 (1.14-1.85) in those who drank ≥ 20 g/day. Additionally, interaction was found between 1p11.2-rs11249433 and ever being parous (Pinteraction = 5.3 × 10(-5)), with a per-allele OR of 1.14 (1.11-1.17) in parous women and 0.98 (0.92-1.05) in nulliparous women. These data provide first strong evidence that the risk of breast cancer associated with some common genetic variants may vary with environmental risk factors.

Indexed as

Gene-Environment InteractionGenetic Association StudiesAllelesBreast NeoplasmsCaspase 8FemaleGenetic Predisposition to DiseaseGenotypeHumansMicrofilament ProteinsMiddle AgedPolymorphism, Single NucleotideRisk FactorsWhite PeopleCASP8 protein, humanCaspase 8LSP1 protein, humanMicrofilament Proteins

Identifiers

PMID23544014
PMCPMC3609648
OpenAlexW2074801231

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.